Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4031)
All Articles published online
|
Nov 28, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pagán B, Isidro AA, Cruz ML, Ren Y, Coppola D, Wu J, Appleyard CB. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol 2011; 17(44): 4858-4866 [PMID: 22171126 DOI: 10.3748/wjg.v17.i44.4858] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i44/4858.htm |
| Number | Citing Articles |
| 1 |
Marvin B. Brooks. Erlotinib and Gefitinib, Epidermal Growth Factor Receptor Kinase Inhibitors, May Treat Non-Cancer-Related Tumor Necrosis Factor-α Mediated Inflammatory Diseases. The Oncologist 2013; 18(1): e3 doi: 10.1634/theoncologist.2012-0219
|
| 2 |
Sahil Kumar, Bandna Sharma, Tilak R. Bhardwaj, Rajesh K. Singh. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(3): 383 doi: 10.2174/1871520620666200811124013
|
| 3 |
Wu Yuan, Yan Feng, Defu Chen, Payam Gharibani, Jiande D. Z. Chen, Huimin Yu, Xingde Li. In vivo assessment of inflammatory bowel disease in rats with ultrahigh-resolution colonoscopic OCT. Biomedical Optics Express 2022; 13(4): 2091 doi: 10.1364/BOE.453396
|
| 4 |
Raymond A Isidro, Myrella L Cruz, Angel A Isidro, Axel Baez, Axel Arroyo, William A González-Marqués, Carmen González-Keelan, Esther A Torres, Caroline B Appleyard. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World Journal of Gastroenterology 2015; 21(6): 1749-1758 doi: 10.3748/wjg.v21.i6.1749
|
| 5 |
Büşra Karaca, Elçin Bakır, Mükerrem Betül Yerer, Ahmet Cumaoğlu, Zuhal Hamurcu, Ayşe Eken. Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β‐catenin signaling pathways. Journal of Biochemical and Molecular Toxicology 2021; 35(11) doi: 10.1002/jbt.22905
|
| 6 |
Maged E. Mohamed, Azza M. El-Shafae, Eman Fikry, Samar S. Elbaramawi, Mahmoud H. Elbatreek, Nora Tawfeek. Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1322181
|
| 7 |
Max Liu, Xiaoying S. Zhong, Srikruthi S. Krishnachaitanya, Rongliwen Ou, Roderick H. Dashwood, Don W. Powell, Qingjie Li. Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer. Biomedicine & Pharmacotherapy 2024; 175: 116580 doi: 10.1016/j.biopha.2024.116580
|
| 8 |
Jianchun Chen, Fenghua Zeng, Steven J. Forrester, Satoru Eguchi, Ming-Zhi Zhang, Raymond C. Harris. Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease. Physiological Reviews 2016; 96(3): 1025 doi: 10.1152/physrev.00030.2015
|
| 9 |
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, Sally E. Abu-Risha, Marwa E. Abdelmageed. Eicosapentaenoic acid mitigates ulcerative colitis-induced by acetic acid through modulation of NF-κB and TGF-β/ EGFR signaling pathways. Life Sciences 2023; 327: 121820 doi: 10.1016/j.lfs.2023.121820
|
| 10 |
Ahmet M. Ulusan, Praveen Rajendran, Wan Mohaiza Dashwood, Omer F. Yavuz, Sabeeta Kapoor, Trace A. Gustafson, Michelle I. Savage, Powel H. Brown, Shizuko Sei, Altaf Mohammed, Eduardo Vilar, Roderick H. Dashwood. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP). Cancer Prevention Research 2021; 14(3): 325 doi: 10.1158/1940-6207.CAPR-20-0262
|
| 11 |
Yanlin Song, Ming Chen, Yuhao Wei, Xuelei Ma, Huashan Shi. Signaling pathways in colorectal cancer: implications for the target therapies. Molecular Biomedicine 2024; 5(1) doi: 10.1186/s43556-024-00178-y
|